DRUGS, MEDICAL DEVICES AND BIOLOGICS QUICK FACTS

Attorneys focused on therapeutic products, including

    former agency officials

HONORS AND AWARDS

Ranked in U.S. News-Best Lawyers "Best Law Firms" for FDA Law, 2012 - 2017

 

PRACTICE FOCUS

505(b)(2) NDAs

Anti-kickback laws

APA challenges

BLA licensing

Citizen petitions

Class action suits

Clinical studies

Corporate integrity agreements

Exclusivity

False Claims Act

FDA inspections

Good manufacturing practices

Hatch-Waxman Act

Lanham Act lawsuits

Medicare and Medicaid

NAD challenges

NDA and ANDA approvals

Off-label use and promotion

OTC drug advertising

OTC drug monographs

OTC switches

Patent certifications

Patent infringement lawsuits

Patent listings

PMA approval and 510(k) clearances

Prescription drug advertising

Pricing, reporting and compliance

Recalls

Seizures, injunctions and criminal prosecutions

 

Drugs, Medical Devices and Biologics

counsel across the entire product life cycle


Venable attorneys have decades of regulatory experience involving therapeutic products. We help clients at every step of the product life cycle—from product development and regulatory approval/clearance to marketing, advertising and reimbursement.

WE HELP YOU MEET THE CHALLENGES FACING YOUR THERAPEUTIC PRODUCT

Drugs, Medical Devices and Biologicals image

Getting to market.

Drugs (human and veterinary), devices and biologics are strictly regulated by the Food and Drug Administration (FDA). The requirements for market entry can be complex and onerous. Over-the-counter (OTC) drug monographs, NDAs, ANDAs, PMAs, 510(k)s, BLAs—all can pose significant challenges. To navigate in a complex environment that often involves multiple players, each seeking a competitive advantage, you need sophisticated legal and regulatory skills.

Protecting and challenging intellectual property.

Protecting your patents, trade secrets, trademarks and copyrights is critical throughout the process. Our attorneys are leaders in these areas. We structure and negotiate licenses, research contracts and technology transfer agreements. And we know how to protect your product and preserve your ability to market and profit from it in a competitive environment.

Marketing your product.

Once a therapeutic product makes it to market, it becomes one of the most closely regulated products in the world—subject to a diverse set of regulatory concerns. The FDA regulates the manufacturing, distribution and labeling for therapeutics and monitors prescription drug advertising. The Federal Trade Commission (FTC) regulates advertising for medical devices and OTC drugs.

We practice before those agencies and draw upon the experience of Venable attorneys who have served in high positions at each agency. We are also leaders in litigation against competitors under the Lanham Act and other state and federal statutes under which marketing claims may be challenged.

Getting reimbursed.

Venable attorneys are experienced in federal and state reimbursement issues and can help you secure and maintain reimbursement under Medicare, Medicaid and other state and federal programs. We also provide critical advice regarding the False Claims Act and anti-kickback laws and have negotiated corporate integrity agreements on behalf of clients.

Being aggressive.

You may need to assert your interests aggressively—by challenging the regulators or challenging your competitors. We are leaders in advocacy before the FDA and the FTC, and in bringing them to court.

We also know how to address bad behavior on the part of your competitors through challenges to false advertising under the Lanham Act and other state and federal statutes.

Help when trouble strikes.

We’re well equipped to protect you when the challenges come your way. We have years of experience in dealing with:

  • seizures, injunctions and other enforcement actions brought by the FDA and FTC;
  • FDA warning letters, inspections, recalls and import detentions;
  • government challenges before the FDA, FTC and state attorneys general;
  • competitor challenges to advertising in proceedings before NAD and ERSP;
  • patent, trademark and copyright litigation;
  • false advertising (Lanham Act) litigation;
  • inquiries by state attorneys general; and
  • other challenges faced by companies bringing therapeutic products to market.

What Venable offers: (1) Attorneys with decades of experience helping clients cope with regulatory rules and enforcement policies. (2) Former agency officials with first-hand knowledge of the priorities and trends in product approval. (3) Advice that is practical—based on our experience with the realities of the development, approval and marketing of therapeutic products.